| Literature DB >> 28784732 |
Sunita Desai1, Laura A Hatfield2, Andrew L Hicks3, Anna D Sinaiko4, Michael E Chernew5, David Cowling6, Santosh Gautam7, Sze-Jung Wu8, Ateev Mehrotra9.
Abstract
Insurers, employers, and states increasingly encourage price transparency so that patients can compare health care prices across providers. However, the evidence on whether price transparency tools encourage patients to receive lower-cost care and reduce overall spending remains limited and mixed. We examined the experience of a large insured population that was offered a price transparency tool, focusing on a set of "shoppable" services (lab tests, office visits, and advanced imaging services). Overall, offering the tool was not associated with lower shoppable services spending. Only 12 percent of employees who were offered the tool used it in the first fifteen months after it was introduced, and use of the tool was not associated with lower prices for lab tests or office visits. The average price paid for imaging services preceded by a price search was 14 percent lower than that paid for imaging services not preceded by a price search. However, only 1 percent of those who received advanced imaging conducted a price search. Simply offering a price transparency tool is not sufficient to meaningfully decrease health care prices or spending. Project HOPE—The People-to-People Health Foundation, Inc.Entities:
Keywords: Consumer Issues; Cost of Health Care; Health Economics; Health Spending
Mesh:
Year: 2017 PMID: 28784732 DOI: 10.1377/hlthaff.2016.1636
Source DB: PubMed Journal: Health Aff (Millwood) ISSN: 0278-2715 Impact factor: 6.301